Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis

Genetic deletion of pyruvate kinase muscle 2 (PKM2) in myeloid cells or limiting its nuclear translocation reduced atherosclerosis by suppressing inflammation and enhancing efferocytosis.